Page last updated: 2024-10-23
benzbromarone and Dyslipidemia
benzbromarone has been researched along with Dyslipidemia in 1 studies
Benzbromarone: Uricosuric that acts by increasing uric acid clearance. It is used in the treatment of gout.
benzbromarone : 1-Benzofuran substituted at C-2 and C-3 by an ethyl group and a 3,5-dibromo-4-hydroxybenzoyl group respectively. An inhibitor of CYP2C9, it is used as an anti-gout medication.
Research Excerpts
Excerpt | Relevance | Reference |
---|---|---|
"Therefore, 35." | 1.51 | Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients. ( Fuller, R; Goldenstein-Schainberg, C; Hoff, LS, 2019) |
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Hoff, LS | 1 |
Goldenstein-Schainberg, C | 1 |
Fuller, R | 1 |
Other Studies
1 other study available for benzbromarone and Dyslipidemia
Article | Year |
---|---|
Nephrolithiasis in gout: prevalence and characteristics of Brazilian patients.
Topics: Adult; Asymptomatic Diseases; Benzbromarone; Brazil; Cross-Sectional Studies; Diabetes Mellitus; Diu | 2019 |